News | Artificial Intelligence | February 23, 2021

icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio

icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio

February 23, 2021 — icometrix, world leader in imaging artificial intelligence (AI) solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio. The announcement follows the FDA-clearance and CE-marking of its image processing software for the analysis and communication of the tissue perfusion state on computed tomography (CT) perfusion scans in patients with ischemic stroke. icobrain cva provides physicians with fast, fully automated, and state-of-the-art insights to support treatment decisions in acute ischemic stroke.

Since 2018, treatment guidelines for stroke have expanded the treatment window for mechanical thrombectomy from 6 to 24 hours. Treatment for ischemic stroke is not without risk and requires careful patient selection based on their tissue status. The automated assessment of tissue parameters in an acute clinical setting by icobrain cva will allow more patients to get the right treatment and can improve patient outcomes and care while increasing efficiency.

"With the launch of icobrain cva we address a persisting need in the treatment of acute ischemic stroke. By democratizing advanced CT perfusion analysis for healthcare systems worldwide we take the next step in our mission to become a holistic brain solution provider," said Wim Van Hecke, CEO at icometrix.

"The main challenge of current stroke solutions is correctly identifying the entry point of the injected contrast in the brain. icobrain cva introduces new, patented, deep learning technology into this identification process to achieve a more robust assessment of the infarcted area," explained Dirk Smeets, CTO at icometrix.

icobrain cva is a fully-automated CE-marked and FDA-cleared software solution for the quantitative assessment of tissue perfusion on CT. icobrain cva reports the volume of the core and perfusion lesion by quantifying reduced cerebral blood flow, volume, and transit time. The report includes information on the correctness of the selected arterial input function and the quality of the output. icobrain cva is a cloud-based solution, returning a report and perfusion maps straight into your PACS and e-mail inbox.

For more information: icometrix.com


Related Content

News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | FDA

Nov. 26, 2025 — a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and ...

Time December 03, 2025
arrow
News | Information Technology

Dec. 1, 2025 — BioSked has announced a major expansion of its Momentum scheduling platform, introducing one of the first ...

Time December 03, 2025
arrow
News | Radiology Imaging

Dec. 1, 2025 — Rad AI has launched next-generation speech recognition technology (patent pending) that dramatically ...

Time December 02, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers is presenting its new imaging chain Optiq AI1, which is powered by ...

Time December 01, 2025
arrow
News | X-Ray

Dec. 1, 2025 — Medimaps Group S.A., a provider of AI-driven bone microarchitecture imaging solutions, will make the ...

Time December 01, 2025
arrow
News | RSNA 2025

Nov. 27, 2025— AdvaHealth Solutions is highlighting AdvaPACS, its cloud-native and AI-forward imaging platform at RSNA ...

Time November 29, 2025
arrow
News | FDA

Nov. 25, 2025 — RapidAI has announced the U.S. Food and Drug Administration (FDA) clearance of five new imaging modules ...

Time November 25, 2025
arrow
News | RSNA 2025

Nov. 13, 2025 — Nano-X Imaging Ltd., a medical imaging technology company, will showcase its Nanox.ARC X multi-source ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
Subscribe Now